Risk of serotonin syndrome in patients prescribed triptans for migraine, antidepressants

(JAMA Network) The risk of serotonin syndrome in patients prescribed both triptans for migraine and antidepressants appears to be low, which may suggest an advisory from the US Food and Administration on that risk should be reconsidered.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news